vs
Acadia Healthcare Company, Inc.（ACHC）とCARLISLE COMPANIES INC（CSL）の財務データ比較。上の社名をクリックして会社を切り替えられます
CARLISLE COMPANIES INCの直近四半期売上が大きい（$1.1B vs $829.0M、Acadia Healthcare Company, Inc.の約1.3倍）。CARLISLE COMPANIES INCの純利益率が高く（12.1% vs 0.5%、差は11.6%）。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い（7.5% vs -4.0%）。過去8四半期でAcadia Healthcare Company, Inc.の売上複合成長率が高い（2.0% vs -14.8%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
カーライル・カンパニーズ・インクは建設製品のサプライヤーで、建物の省エネ性と耐久性向上に寄与する製品を提供している。商業建築向け単層屋根材、保証付きシステム、付属品の製造・販売を手がけ、建設資材、防水技術の2事業セグメントの下、防潮材、屋根用保護材などをラインナップしている。
ACHC vs CSL — 直接比較
損益計算書 — Q1 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $1.1B |
| 純利益 | $4.5M | $127.7M |
| 粗利率 | — | 34.5% |
| 営業利益率 | — | 17.1% |
| 純利益率 | 0.5% | 12.1% |
| 売上前年比 | 7.5% | -4.0% |
| 純利益前年比 | -50.8% | -10.9% |
| EPS（希薄化後） | $0.05 | $3.10 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | $1.1B | ||
| Q4 25 | $821.5M | $1.1B | ||
| Q3 25 | $851.6M | $1.3B | ||
| Q2 25 | $869.2M | $1.4B | ||
| Q1 25 | $770.5M | $1.1B | ||
| Q4 24 | $774.2M | $1.1B | ||
| Q3 24 | $815.6M | $1.3B | ||
| Q2 24 | $796.0M | $1.5B |
| Q1 26 | $4.5M | $127.7M | ||
| Q4 25 | $-1.2B | $127.4M | ||
| Q3 25 | $36.2M | $214.2M | ||
| Q2 25 | $30.1M | $255.8M | ||
| Q1 25 | $8.4M | $143.3M | ||
| Q4 24 | $32.6M | $162.8M | ||
| Q3 24 | $68.1M | $244.3M | ||
| Q2 24 | $78.5M | $712.4M |
| Q1 26 | — | 34.5% | ||
| Q4 25 | — | 33.8% | ||
| Q3 25 | — | 36.0% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 39.2% |
| Q1 26 | — | 17.1% | ||
| Q4 25 | -142.4% | 16.8% | ||
| Q3 25 | 4.7% | 21.8% | ||
| Q2 25 | 5.8% | 23.1% | ||
| Q1 25 | 1.7% | 16.8% | ||
| Q4 24 | 4.9% | 19.9% | ||
| Q3 24 | 12.1% | 23.7% | ||
| Q2 24 | 13.4% | 26.0% |
| Q1 26 | 0.5% | 12.1% | ||
| Q4 25 | -143.3% | 11.3% | ||
| Q3 25 | 4.3% | 15.9% | ||
| Q2 25 | 3.5% | 17.6% | ||
| Q1 25 | 1.1% | 13.1% | ||
| Q4 24 | 4.2% | 14.5% | ||
| Q3 24 | 8.4% | 18.3% | ||
| Q2 24 | 9.9% | 49.1% |
| Q1 26 | $0.05 | $3.10 | ||
| Q4 25 | $-12.98 | $3.06 | ||
| Q3 25 | $0.40 | $4.98 | ||
| Q2 25 | $0.33 | $5.88 | ||
| Q1 25 | $0.09 | $3.20 | ||
| Q4 24 | $0.36 | $3.76 | ||
| Q3 24 | $0.74 | $5.25 | ||
| Q2 24 | $0.85 | $14.84 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $771.3M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $2.0B | $1.7B |
| 総資産 | $5.5B | — |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | $771.3M | ||
| Q4 25 | $133.2M | $1.1B | ||
| Q3 25 | $118.7M | $1.1B | ||
| Q2 25 | $131.4M | $68.4M | ||
| Q1 25 | $91.2M | $220.2M | ||
| Q4 24 | $76.3M | $753.5M | ||
| Q3 24 | $82.1M | $1.5B | ||
| Q2 24 | $77.2M | $1.7B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | $2.3B | $2.9B | ||
| Q2 25 | $2.3B | $1.9B | ||
| Q1 25 | $2.2B | $1.9B | ||
| Q4 24 | $2.0B | $1.9B | ||
| Q3 24 | $1.9B | $2.3B | ||
| Q2 24 | $1.8B | $2.3B |
| Q1 26 | $2.0B | $1.7B | ||
| Q4 25 | $1.9B | $1.8B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $2.1B | ||
| Q1 25 | $3.0B | $2.2B | ||
| Q4 24 | $3.1B | $2.5B | ||
| Q3 24 | $3.0B | $2.8B | ||
| Q2 24 | $3.0B | $3.0B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $6.3B | ||
| Q3 25 | $6.4B | $6.5B | ||
| Q2 25 | $6.3B | $5.5B | ||
| Q1 25 | $6.1B | $5.5B | ||
| Q4 24 | $6.0B | $5.8B | ||
| Q3 24 | $5.9B | $6.5B | ||
| Q2 24 | $5.7B | $6.7B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 1.61× | ||
| Q3 25 | 0.74× | 1.45× | ||
| Q2 25 | 0.74× | 0.89× | ||
| Q1 25 | 0.72× | 0.87× | ||
| Q4 24 | 0.64× | 0.77× | ||
| Q3 24 | 0.62× | 0.83× | ||
| Q2 24 | 0.62× | 0.76× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | — |
| フリーキャッシュフロー営業CF - 設備投資 | — | $-73.0M |
| FCFマージンFCF / 売上 | — | -6.9% |
| 設備投資強度設備投資 / 売上 | — | 2.7% |
| キャッシュ転換率営業CF / 純利益 | 13.78× | — |
| 直近12ヶ月FCF直近4四半期 | — | $924.8M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $386.0M | ||
| Q3 25 | $73.2M | $426.9M | ||
| Q2 25 | $133.5M | $287.1M | ||
| Q1 25 | $11.5M | $1.8M | ||
| Q4 24 | $116.7M | $370.6M | ||
| Q3 24 | $163.1M | $312.8M | ||
| Q2 24 | $171.1M | $183.4M |
| Q1 26 | — | $-73.0M | ||
| Q4 25 | $-179.5M | $346.1M | ||
| Q3 25 | $-63.0M | $393.4M | ||
| Q2 25 | $-34.2M | $258.3M | ||
| Q1 25 | $-163.2M | $-27.2M | ||
| Q4 24 | $-86.8M | $334.0M | ||
| Q3 24 | $-27.1M | $293.5M | ||
| Q2 24 | $16.9M | $158.5M |
| Q1 26 | — | -6.9% | ||
| Q4 25 | -21.8% | 30.7% | ||
| Q3 25 | -7.4% | 29.2% | ||
| Q2 25 | -3.9% | 17.8% | ||
| Q1 25 | -21.2% | -2.5% | ||
| Q4 24 | -11.2% | 29.7% | ||
| Q3 24 | -3.3% | 22.0% | ||
| Q2 24 | 2.1% | 10.9% |
| Q1 26 | — | 2.7% | ||
| Q4 25 | 11.3% | 3.5% | ||
| Q3 25 | 16.0% | 2.5% | ||
| Q2 25 | 19.3% | 2.0% | ||
| Q1 25 | 22.7% | 2.6% | ||
| Q4 24 | 26.3% | 3.3% | ||
| Q3 24 | 23.3% | 1.4% | ||
| Q2 24 | 19.4% | 1.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.03× | ||
| Q3 25 | 2.02× | 1.99× | ||
| Q2 25 | 4.43× | 1.12× | ||
| Q1 25 | 1.37× | 0.01× | ||
| Q4 24 | 3.58× | 2.28× | ||
| Q3 24 | 2.39× | 1.28× | ||
| Q2 24 | 2.18× | 0.26× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
CSL
| CCM | $758.0M | 72% |
| CWT | $294.0M | 28% |
